# COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit

> **NIH NIH UM1** · GEORGE WASHINGTON UNIVERSITY · 2020 · $601,947

## Abstract

CPCRA CTU # 60407: Admin Supplement NOT-AI-20-031 & PA-18-591 Principal Investigator: KAN, Virginia L.
PROJECT SUMMARY/ABSTRACT
The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clinical Trials Unit (CTU)
# 60407 is pleased to submit an Administrative Supplement application in response to NOT-AI-20-031 and PA-
18-591 through the George Washington University (GWU), the applicant organization, in collaboration with two
affiliated Clinical Research Sites (CRSs). This CTU is led by Virginia L. Kan, MD, Principal Investigator.
This supplement will provide funding to expand SARS-CoV-2 testing at the following two CTU-affiliated Clinical
Research Sites:
Site 01: George Washington University (GWU) CRS # 31608, Washington, DC
Site 02: Houston AIDS Research Team (HART) CRS # 31473, Houston, TX

## Key facts

- **NIH application ID:** 10166265
- **Project number:** 3UM1AI069503-14S1
- **Recipient organization:** GEORGE WASHINGTON UNIVERSITY
- **Principal Investigator:** Virginia Kan
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $601,947
- **Award type:** 3
- **Project period:** 2020-06-04 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10166265

## Citation

> US National Institutes of Health, RePORTER application 10166265, COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit (3UM1AI069503-14S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10166265. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*